Japan, Sept. 28 -- MEREO BIOPHARMA 3 LTD has got intellectual property rights for 'USE OF ANTI-SCLEROSTIN ANTIBODIES IN TREATMENT OF OSTEOGENESIS IMPERFECTA.' Other related details are as follows:
Application Number: JP,2021-200994
Category (FI): A61K33/16,A61K39/395@D,A61K39/395@N,A61P19/08,A61K45/00,A61K31/137,A61K33/24,A61K33/00,A61K9/19,A61K47/26,A61K47/18,A61K47/14,C07K16/18,A61P19/10,A61K47/04
Stage: Grant (IP right granted following substantive examination.)
Filing Date: Dec. 10, 2021
Publication Date: March 23, 2022
The original document can be viewed at: https://www.j-platpat.inpit.go.jp/p0100
Disclaimer: Curated by HT Syndication.
